Business Insider

SI-BONE, Inc. Announces Publication of 3-Year Long-term Prospective Outcomes Including Randomized Controlled Trial Data on 103 Patients Post SI Joint Fusion with Triangular ...

SAN JOSE, Calif., April 9, 2018 /PRNewswire/ -- SI-BONE, Inc., a medical device company that pioneered the minimally invasive surgical (MIS) treatment of the sacroiliac (SI) joint with the iFuse ...
Nasdaq

SI-BONE, Inc. Announces Aetna Establishes Positive Coverage for MIS SI Joint Fusion using the Triangular iFuse Implant System

New positive coverage policy further validates acceptance of iFuse as an important treatment option for patients with chronic sacroiliac joint dysfunction SANTA CLARA, Calif., May 29, 2020 (GLOBE ...
Business Insider

SI-BONE, Inc. Announces Publication of 3-Year Long-term Prospective Outcomes Including Randomized Controlled Trial Data on 103 Patients Post SI Joint Fusion with Triangular ...

Results include 57 Patients at 4 years showing continued durability SAN JOSE, California, April 9, 2018 /PRNewswire/ -- SI-BONE, Inc., a medical device company that pioneered the minimally invasive ...